Annual Spring CPD

 

Date: March 27, 2025
Location: Ivey Spencer Leadership Center
In-person only

Thank you to all those who attended

Overall Learning Objectives:

At the conclusion of this presentation, participants will be able to:

1. Describe the approach to the investigation, diagnosis, and treatment of seizures in children and adolescents
2. Review the common presentation of neuromotor disorders as well as their diagnosis and treatment modalities
3. Explain the rational approach to pharmacological treatment of interfering behaviours in people with developmental disabilities.

Agenda

12:00PM Lunch (provided for all attendees) 1:00PM -1:05PM Welcome and Introductory Remarks – Dr. Greg Gillis 1:05PM – 1:55PM The Approach to Epilepsy in Children and Adolescents - Dr. Egidio Spinelli 1:55PM – 2:45PM A Comprehensive Approach to Cerebral Palsy Diagnosis and Management: Supporting Development Throughout Childhood - Dr. Sarah Pilon 2:45PM – 3:00PM Break 3:00PM – 3:50PM Pharmacological Treatment of Interfering Behaviours in Developmental Disabilities - Dr. Rob Nicolson 3:50PM – 4:00PM Closing Remarks – Dr. Greg Gillis

Session specific learning objectives

Presentation Learning Objectives
The Approach to Epilepsy in Children and Adolescents
- Dr. Egidio Spinelli
  1. Describe the investigation of seizures in children and adolescents
  2. Explain the approach to treatment of seizures in children and adolescents
  3. Review the appropriate monitoring of anti-epileptic drugs in children and adolescents
A Comprehensive Approach to Cerebral Palsy Diagnosis and Management: Supporting Development Throughout Childhood
- Dr. Sarah Pilon
  1. Recognize red flags for cerebral palsy, use appropriate screening tools for timely diagnosis, and apply the classification systems employed.
  2. Describe local referral pathways for early intervention and identify resources available to support the diagnosis and ongoing management of cerebral palsy for both healthcare providers and families.
  3. Adopt a multidisciplinary approach to managing cerebral palsy, developing individualized care plans focused on functional outcomes and appropriate interventions.

Pharmacological Treatment of Interfering Behaviours in Developmental Disabilities
- Dr. Rob Nicolson
  1. Describe the common reasons for the initiation of psychopharmacological treatment in people with developmental disabilities
  2. Explain the approach to the treatment of aggression in people with developmental disabilities
  3. Elucidate the treatment of inattention and hyperactivity in people with developmental disabilities

Accreditation Information

This activity meets the certification criteria of the College of Family Physicians of Canada and has been certified by Continuing Professional Development, Schulich School of Medicine & Dentistry, Western University for up to 2.50 Mainpro+® Certified Activity credits.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by Continuing Professional Development, Schulich School of Medicine & Dentistry, Western University. You may claim a maximum of 2.50 hours (credits are automatically calculated).

The developmental disabilities program is approved by the Canadian psychological association to offer continuing education for psychologists. The developmental dis-abilities program maintains responsibility for the program.

Each participant should claim only those hours of credit that they actually spent participating in the educational program.

 

 Contact: Jason Widdes jason.widdes@sjhc.london.on.ca